Marker Therapeutics, Inc. (MRKR)
1.31
+0.01
(+0.77%)
USD |
NASDAQ |
Apr 01, 16:00
1.31
0.00 (0.00%)
After-Hours: 20:00
Marker Therapeutics Research and Development Expense (TTM) : 11.80M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Viridian Therapeutics, Inc. | 338.47M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| electroCore, Inc. | 2.735M |
| Kiniksa Pharmaceuticals International Plc | 96.66M |
| Agenus, Inc. | 79.34M |